Profile for European Patent Office Patent: 2487163
✉ Email this page to a colleague
Country | SPC | SPC Expiration |
---|---|---|
Lithuania | PA2016039 | ⤷ Sign Up |
Netherlands | 300859 | ⤷ Sign Up |
Germany | 122016000120 | ⤷ Sign Up |
Austria | 60/2016 | ⤷ Sign Up |
Denmark | CA 2017 00003 | ⤷ Sign Up |
Estonia | C20170001 00217 | ⤷ Sign Up |
US Patent Family Members and Approved Drugs for European Patent Office Patent: 2487163
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
⤷ Sign Up | Sep 3, 2029 | Bristol | EVOTAZ | atazanavir sulfate; cobicistat |
⤷ Sign Up | Sep 3, 2029 | Janssen Prods | PREZCOBIX | cobicistat; darunavir |
⤷ Sign Up | Sep 3, 2029 | Janssen Prods | SYMTUZA | cobicistat; darunavir; emtricitabine; tenofovir alafenamide fumarate |
⤷ Sign Up | Mar 3, 2030 | Gilead Sciences Inc | GENVOYA | cobicistat; elvitegravir; emtricitabine; tenofovir alafenamide fumarate |
⤷ Sign Up | Mar 3, 2030 | Gilead Sciences Inc | STRIBILD | cobicistat; elvitegravir; emtricitabine; tenofovir disoproxil fumarate |
⤷ Sign Up | Mar 3, 2030 | Gilead Sciences Inc | TYBOST | cobicistat |
>US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |